AMLX
Price
$3.54
Change
+$0.11 (+3.21%)
Updated
Apr 7, 02:29 PM (EDT)
Capitalization
303.91M
31 days until earnings call
CRBU
Price
$0.74
Change
-$0.03 (-3.90%)
Updated
Apr 7, 02:32 PM (EDT)
Capitalization
71.2M
36 days until earnings call
Ad is loading...

AMLX vs CRBU

Header iconAMLX vs CRBU Comparison
Open Charts AMLX vs CRBUBanner chart's image
Amylyx Pharmaceuticals
Price$3.54
Change+$0.11 (+3.21%)
Volume$3.62K
Capitalization303.91M
Caribou Biosciences
Price$0.74
Change-$0.03 (-3.90%)
Volume$100
Capitalization71.2M
AMLX vs CRBU Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. CRBU commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and CRBU is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (AMLX: $3.43 vs. CRBU: $0.77)
Brand notoriety: AMLX and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 117% vs. CRBU: 88%
Market capitalization -- AMLX: $303.91M vs. CRBU: $71.2M
AMLX [@Biotechnology] is valued at $303.91M. CRBU’s [@Biotechnology] market capitalization is $71.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than CRBU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • CRBU’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMLX and CRBU are a good buy in the short-term.

Price Growth

AMLX (@Biotechnology) experienced а -6.28% price change this week, while CRBU (@Biotechnology) price change was -18.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.53%. For the same industry, the average monthly price growth was -18.02%, and the average quarterly price growth was -17.39%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

CRBU is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-9.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($304M) has a higher market cap than CRBU($71.2M). AMLX YTD gains are higher at: -9.259 vs. CRBU (-51.730). CRBU has higher annual earnings (EBITDA): -162.69M vs. AMLX (-290.98M). CRBU has more cash in the bank: 210M vs. AMLX (177M). AMLX has less debt than CRBU: AMLX (1.98M) vs CRBU (26.5M). AMLX has higher revenues than CRBU: AMLX (87.4M) vs CRBU (9.99M).
AMLXCRBUAMLX / CRBU
Capitalization304M71.2M427%
EBITDA-290.98M-162.69M179%
Gain YTD-9.259-51.73018%
P/E Ratio2.69N/A-
Revenue87.4M9.99M875%
Total Cash177M210M84%
Total Debt1.98M26.5M7%
TECHNICAL ANALYSIS
Technical Analysis
AMLXCRBU
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 18 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNRC111.86-3.78
-3.27%
Generac Holdings
VTYX0.94-0.06
-6.02%
Ventyx Biosciences
JPM210.28-17.01
-7.48%
JPMorgan Chase & Co
DAN11.26-1.18
-9.49%
Dana
PRCH5.64-0.81
-12.56%
Porch Group

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-2.28%
XOMAO - AMLX
68%
Closely correlated
-0.75%
IKNA - AMLX
54%
Loosely correlated
-5.83%
XOMAP - AMLX
51%
Loosely correlated
-0.54%
CRBU - AMLX
43%
Loosely correlated
-2.23%
JAZZ - AMLX
43%
Loosely correlated
-8.92%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CCCC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-2.23%
CCCC - CRBU
55%
Loosely correlated
-4.73%
FATE - CRBU
54%
Loosely correlated
+10.72%
CRSP - CRBU
53%
Loosely correlated
-0.03%
ALLO - CRBU
52%
Loosely correlated
+4.35%
NKTX - CRBU
51%
Loosely correlated
-4.40%
More